This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Korea University Research and Business Foundation, Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2022.
Company Filing History:
1 out of 1,262 
1 out of 363 Years Active: 2022
Title: Chan-Sik Yang: Innovator in Cardiovascular Treatment
Introduction
Chan-Sik Yang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of cardiovascular diseases. His innovative work has led to the development of a novel compound that holds promise for improving patient outcomes.
Latest Patents
Chan-Sik Yang holds 1 patent for his invention titled "N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease." This patent describes a unique N-acylurea derivative that can inhibit platelet aggregation by targeting the activity of talin in the intracellular matrix. The pharmaceutical composition developed from this derivative is aimed at preventing or treating cardiovascular diseases, showcasing its potential therapeutic benefits.
Career Highlights
Throughout his career, Chan-Sik Yang has been associated with several esteemed institutions. He has worked with the Osong Medical Innovation Foundation, Korea University Research and Business Foundation, and Kyungpook National University Industry-Academic Cooperation Foundation. His roles in these organizations have allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Chan-Sik Yang has collaborated with notable colleagues, including Soon Jun Hong and Chung Ho Kim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field of cardiovascular treatment.
Conclusion
Chan-Sik Yang's innovative contributions to cardiovascular medicine through his patented N-acylurea derivative highlight his role as a key inventor in this critical area of healthcare. His work continues to pave the way for advancements in treatment options for cardiovascular diseases.